Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods

Figure 2

EPCAM expression in the different clinical settings. EPCAM levels (ng/μL) by RT-PCR in samples processed by AdnaTest approach are reported for each clinical setting (patients with muscle-invasive nonmetastatic bladder cancer, ; patients with bladder cancer under first-line, , or after second-line, , therapy) and for each time point analyzed: baseline (, green dots), after the first (, yellow dots), and after the second (, red dots) cycle of therapy.